Log in to save to my catalogue

Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expressi...

Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expressi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9750878

Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner

About this item

Full title

Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner

Publisher

New York: Nature Publishing Group US

Journal title

Cancer gene therapy, 2022-12, Vol.29 (12), p.1975-1987

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Silencing of the
Apoptosis associated Tyrosine Kinase
gene (
AATK
) has been described in cancer. In our study, we specifically investigated the epigenetic inactivation of
AATK
in pancreatic adenocarcinoma, lower grade glioma, lung, breast, head, and neck cancer. The resulting loss of
AATK
correlates with impaired patient su...

Alternative Titles

Full title

Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9750878

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9750878

Other Identifiers

ISSN

0929-1903

E-ISSN

1476-5500

DOI

10.1038/s41417-022-00513-x

How to access this item